APLLTD — Alembic Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
- IN₹194.65bn
- IN₹201.81bn
- IN₹56.53bn
- 98
- 15
- 99
- 86
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 39,347 | 46,058 | 53,931 | 53,058 | 56,526 |
Cost of Revenue | |||||
Gross Profit | 26,524 | 31,892 | 37,531 | 34,618 | 34,779 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 31,938 | 35,921 | 40,963 | 47,183 | 52,148 |
Operating Profit | 7,409 | 10,136 | 12,968 | 5,875 | 4,378 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,493 | 9,998 | 13,681 | 6,201 | 3,855 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,926 | 8,006 | 11,148 | 5,157 | 3,729 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5,844 | 8,288 | 11,465 | 5,209 | 3,420 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5,844 | 8,288 | 11,465 | 5,209 | 3,420 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 31 | 48.1 | 59.1 | 26.5 | 17.6 |
Dividends per Share | |||||
Special Dividends per Share |